QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 210 filers reported holding QIAGEN NV in Q3 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $123,000 | -30.9% | 4,390 | -32.5% | 0.01% | -41.7% |
Q3 2016 | $178,000 | +1269.2% | 6,508 | +918.5% | 0.01% | +1100.0% |
Q2 2016 | $13,000 | +8.3% | 639 | +38.6% | 0.00% | 0.0% |
Q4 2015 | $12,000 | 0.0% | 461 | -8.0% | 0.00% | 0.0% |
Q3 2015 | $12,000 | +100.0% | 501 | +78.9% | 0.00% | 0.0% |
Q2 2015 | $6,000 | +100.0% | 280 | +79.5% | 0.00% | – |
Q1 2015 | $3,000 | -97.0% | 156 | -96.3% | 0.00% | -100.0% |
Q4 2014 | $100,000 | – | 4,242 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |